Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	114	60	33	27	33	69
Market Cap Growth	148.96%	78.87%	24.62%	-17.94%	-52.77%	55.54%
Enterprise Value	115	54	37	27	31	59
Last Close Price	7.61	3.09	1.84	1.39	1.74	3.62

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Forward PE	-	24.00	24.00	24.00	24.00	24.00
PS Ratio	2.57	1.34	0.88	0.68	0.78	1.92
PB Ratio	6.54	2.42	1.48	0.91	0.91	1.62
P/TBV Ratio	6.56	5.99	8.39	4.39	6.84	3.83
P/FCF Ratio	166.72	12.31	-	4.59	3.90	11.04
P/OCF Ratio	152.85	12.07	-	4.38	3.85	10.86
PEG Ratio	-	1.52	1.52	1.52	1.52	1.52

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	2.59	1.22	0.98	0.67	0.73	1.65
EV/EBITDA Ratio	104.74	40.09	-	-	-	-
EV/FCF Ratio	167.97	11.22	-	4.56	3.67	9.49

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.28	0.42	0.91	0.63	0.58	0.38
Debt / EBITDA Ratio	1.42	2.83	50.39	32.10	15.97	-
Debt / FCF Ratio	6.89	2.11	-	3.17	2.51	2.57
Net Debt / Equity Ratio	0.05	-0.05	0.12	0.00	0.03	-0.26
Net Debt / EBITDA Ratio	0.78	-0.93	-1.70	-0.08	-3.19	3.58
Net Debt / FCF Ratio	1.25	-0.26	-3.84	0.02	0.14	-1.76
Asset Turnover	0.68	0.58	0.48	0.45	0.47	0.40
Inventory Turnover	4.10	1.30	1.53	0.84	1.00	0.92
Quick Ratio	0.49	0.77	0.94	1.00	1.15	1.76
Current Ratio	0.96	1.01	1.15	1.28	1.61	2.37
Return on Equity (ROE)	-14.39%	-12.17%	-24.88%	-19.41%	-14.38%	-12.51%
Return on Assets (ROA)	-2.91%	-2.29%	-5.11%	-4.44%	-4.02%	-5.30%
Return on Invested Capital (ROIC)	-15.88%	-11.53%	-23.60%	-18.67%	-16.59%	-21.68%
Return on Capital Employed (ROCE)	-11.00%	-7.00%	-14.60%	-11.50%	-8.90%	-11.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-9.58%	-4.76%	-19.47%	-23.51%	-17.12%	-5.09%
FCF Yield	0.60%	8.12%	-2.04%	21.77%	25.66%	9.05%
Buyback Yield / Dilution	-2.64%	-5.65%	1.67%	1.82%	2.29%	1.70%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 25, 2026

Data Sources Report a data error